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Partial karyotype showing an unbalanced t(3;7)(q26;q21). 
Clinics and pathology 
Note: This translocation has been observed in myeloid 
leukemia [one case of acute myeloid leukemia (AML), 
subtype M4, and two cases of chronic myeloid 
leukemia in blast crisis (CML-BC)]. 
Disease 
Blast crisis chronic myelogenous leukemia (myeloid-
myeloid/NK phenotype). 






Phenotype / cell stem origin 





t(3;7)(q26;q21) in BC-CML; -7,+der(7)t(3;7)(q26;q21) 
in AML M4. 
Probes 
RP11-33A1 (EVI1) RP11-332M5 (CDK6). 
Additional anomalies 
Sole anomaly in AML; Ph chromosome in BC-CML 
patients. 
Variants 
No variants described. 
Genes involved and Proteins 
EVI1 (ecotropic viral integration site 1) 
(alias PRDM3) 
Location: 3q26.2 
Note: EVI1 is expressed at very low levels in normal 
peripheral blood and bone marrow. The gene is 
overexpressed in myeloid leukemias and 
myelodysplastic syndromes as a result of chromosomal 
rearrangements at either the 5' region of the gene in 
t(3;3)(q21;q26) or at the 3' region in inv(3)(q21q26) by 
juxtaposition of the gene to putative enhancer elemnts 
of the Ribophorin I gene in 3q21. High expression of 
EVI1 can also occur in the t(3;21)(q26;q22) as part of 
the fusion gene AML1 / MDS1 /EVI1 in CML-BC, or 
MDS or as part of the fusion gene ETV6 /MDS1/EVI1 
in AML with t(3;12) translocation. EVI1 is also 
involved in other translocations such as 
t(2;3)(p13;q26), t(2;3)(q23;q26), t(3;17)(q26;q22) and 
t(3;13)(q26;q13-14). Other studies have reported 
abnormal expression of EVI1 in MDS and AML 
without 3q26 structural abnormalities, suggesting that 
inappropriate activation of this gene occurs through 
various mechanisms. 
DNA / RNA 
16 exons spanning 64.2 kb. Transcriptional orientation 
is from telomere to centromere. 6 splicing variants. 
Protein 
1051 amino acids; 118335 Da. Nuclear location, 
contains 10 C2H2-type zinc fingers. 
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FISH cohybridization between clones identifying breakpoints on chromosome 3 (RP11-33A1) and 7 (RP11-332M5) in a case of BC-CML 
with a t(3;7)(q21;q26). 
 
CDK6 (cyclin-dependent kinase 6) (alias 
PLSTIRE) 
Location: 7q21.2 
DNA / RNA 
7 exons spanning 229 kb. Transcriptional orientation is 
from telomere to centromere. 
Protein 
326 amino acids; 36938 Da. It belongs to the Ser/Thr 
protein kinase family, CDC2 /CDKX subfamily. It is 
probably involved in the control of the cell cycle. 
Interacts with D-type G1 cyclins. 
Results of the chromosomal 
anomaly 
Hybrid gene 
Note: overexpression of EVI1 in bone marrow; no 
detected CDK6/EVI1 fusion gene in any of the myeloid 
leukemia cases analyzed. 
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